Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing

Lee JM. Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing. J Thorac Cardiovasc Surg. 2024 Oct;168(4):1281-1288. doi: 10.1016/j.jtcvs.2024.03.034. Epub 2024 Apr 20. PMID: 38649111.


Related Posts